JACC:周转再加快——急性心梗低风险患者,PCI术后早期出院不影响结局!

2021-12-14 MedSci原创 MedSci原创

通过使用由结构化的多学科虚拟随访计划支持的路径,选定的低风险患者可以在成功的初级PCI之后安全出院。

在美国,每年约有500000名患者接受经皮冠状动脉介入治疗(PCI),整体花费可达到50亿美元。由于PCI操作后可能出现血管通路并发症或血管闭塞导致的急性冠状动脉缺血事件,PCI患者通常需要在医院过夜观察。

但是这种不良事件的发生风险正随着抗栓治疗的发展与冠状动脉支架的使用而逐渐降低,因此可以考虑于择期PCI术后当日出院,从而增加床位使用率、降低成本及院内感染的发生率。

全球范围内,区域性心脏病发作服务通过初级经皮冠状动脉介入促进早期再灌注,改善了ST段抬高型心肌梗死(STEMI)的临床结果。一次性经皮冠状动脉介入治疗后的早期出院受到了患者的欢迎,并提高了医疗服务的效率。

为了评估针对低风险STEMI患者的新型早期出院路径的安全性和可行性,来自英国伦敦玛丽皇后大学威利安-哈维研究所心血管医学中心的专家开展了相关研究,结果发表在《美国心脏病学会杂志》JACC上。

在2020年3月至2021年6月期间,600名被认为是早期主要不良心血管事件(MACE)低风险的患者被选入该路径,并在<48小时内成功出院。患者在出院后48小时由心脏康复护士进行结构化的电话随访,并在2、6、8周和3个月后进行虚拟随访。

住院时间的中位数是24.6小时(四分位数范围[IQR]:22.7-30.0小时)(路径前中位数:65.9小时[IQR:48.1-120.2小时])。出院后,所有患者都被联系上,没有人失去随访。在271天(IQR:88-318天)的中位随访期间,有2例死亡(0.33%),都是由2019年(出院后>30天)的冠状病毒疾病引起的,心血管死亡率为0%,MACE率为1.2%。

总的来说,这一发现与既往符合路径标准的700名住院时间>48小时的患者(>48小时对照组)相比,在未经调整的分析和倾向匹配的分析中都是有利的(死亡率,0.7%;MACE,1.9%)。

早期出院与48小时候出院患者MACE及死亡率比较

综上,通过使用由结构化的多学科虚拟随访计划支持的路径,选定的低风险患者可以在成功的初级PCI之后安全出院。

 

参考文献:

Early Hospital Discharge Following PCI for Patients With STEMI. J Am Coll Cardiol. 2021 Dec, 78 (25) 2550–2560

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1207554, encodeId=7ebc120e554e1, content=很有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4da6463967, createdName=ms6000000942294328, createdTime=Thu Mar 31 15:00:59 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633868, encodeId=1275163386886, content=<a href='/topic/show?id=578d13843ad' target=_blank style='color:#2F92EE;'>#PCI术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13843, encryptionId=578d13843ad, topicName=PCI术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea4322051797, createdName=zxl736, createdTime=Sun Nov 27 09:17:47 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855027, encodeId=e667185502e32, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Oct 01 10:17:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308401, encodeId=786b130840135, content=<a href='/topic/show?id=8323522e503' target=_blank style='color:#2F92EE;'>#急性心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52275, encryptionId=8323522e503, topicName=急性心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326899, encodeId=1f3d132689907, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486457, encodeId=2d29148645e21, content=<a href='/topic/show?id=76291384571' target=_blank style='color:#2F92EE;'>#PCI术后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13845, encryptionId=76291384571, topicName=PCI术后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ea78134582, createdName=12499e01m49暂无昵称, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080246, encodeId=af52108024691, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73be5472067, createdName=MYR哈哈哈哈, createdTime=Wed Dec 15 09:53:51 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2022-03-31 ms6000000942294328

    很有帮助

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1207554, encodeId=7ebc120e554e1, content=很有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4da6463967, createdName=ms6000000942294328, createdTime=Thu Mar 31 15:00:59 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633868, encodeId=1275163386886, content=<a href='/topic/show?id=578d13843ad' target=_blank style='color:#2F92EE;'>#PCI术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13843, encryptionId=578d13843ad, topicName=PCI术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea4322051797, createdName=zxl736, createdTime=Sun Nov 27 09:17:47 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855027, encodeId=e667185502e32, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Oct 01 10:17:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308401, encodeId=786b130840135, content=<a href='/topic/show?id=8323522e503' target=_blank style='color:#2F92EE;'>#急性心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52275, encryptionId=8323522e503, topicName=急性心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326899, encodeId=1f3d132689907, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486457, encodeId=2d29148645e21, content=<a href='/topic/show?id=76291384571' target=_blank style='color:#2F92EE;'>#PCI术后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13845, encryptionId=76291384571, topicName=PCI术后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ea78134582, createdName=12499e01m49暂无昵称, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080246, encodeId=af52108024691, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73be5472067, createdName=MYR哈哈哈哈, createdTime=Wed Dec 15 09:53:51 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2022-11-27 zxl736
  3. [GetPortalCommentsPageByObjectIdResponse(id=1207554, encodeId=7ebc120e554e1, content=很有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4da6463967, createdName=ms6000000942294328, createdTime=Thu Mar 31 15:00:59 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633868, encodeId=1275163386886, content=<a href='/topic/show?id=578d13843ad' target=_blank style='color:#2F92EE;'>#PCI术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13843, encryptionId=578d13843ad, topicName=PCI术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea4322051797, createdName=zxl736, createdTime=Sun Nov 27 09:17:47 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855027, encodeId=e667185502e32, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Oct 01 10:17:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308401, encodeId=786b130840135, content=<a href='/topic/show?id=8323522e503' target=_blank style='color:#2F92EE;'>#急性心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52275, encryptionId=8323522e503, topicName=急性心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326899, encodeId=1f3d132689907, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486457, encodeId=2d29148645e21, content=<a href='/topic/show?id=76291384571' target=_blank style='color:#2F92EE;'>#PCI术后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13845, encryptionId=76291384571, topicName=PCI术后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ea78134582, createdName=12499e01m49暂无昵称, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080246, encodeId=af52108024691, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73be5472067, createdName=MYR哈哈哈哈, createdTime=Wed Dec 15 09:53:51 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2022-10-01 hbwxf
  4. [GetPortalCommentsPageByObjectIdResponse(id=1207554, encodeId=7ebc120e554e1, content=很有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4da6463967, createdName=ms6000000942294328, createdTime=Thu Mar 31 15:00:59 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633868, encodeId=1275163386886, content=<a href='/topic/show?id=578d13843ad' target=_blank style='color:#2F92EE;'>#PCI术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13843, encryptionId=578d13843ad, topicName=PCI术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea4322051797, createdName=zxl736, createdTime=Sun Nov 27 09:17:47 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855027, encodeId=e667185502e32, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Oct 01 10:17:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308401, encodeId=786b130840135, content=<a href='/topic/show?id=8323522e503' target=_blank style='color:#2F92EE;'>#急性心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52275, encryptionId=8323522e503, topicName=急性心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326899, encodeId=1f3d132689907, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486457, encodeId=2d29148645e21, content=<a href='/topic/show?id=76291384571' target=_blank style='color:#2F92EE;'>#PCI术后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13845, encryptionId=76291384571, topicName=PCI术后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ea78134582, createdName=12499e01m49暂无昵称, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080246, encodeId=af52108024691, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73be5472067, createdName=MYR哈哈哈哈, createdTime=Wed Dec 15 09:53:51 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1207554, encodeId=7ebc120e554e1, content=很有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4da6463967, createdName=ms6000000942294328, createdTime=Thu Mar 31 15:00:59 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633868, encodeId=1275163386886, content=<a href='/topic/show?id=578d13843ad' target=_blank style='color:#2F92EE;'>#PCI术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13843, encryptionId=578d13843ad, topicName=PCI术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea4322051797, createdName=zxl736, createdTime=Sun Nov 27 09:17:47 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855027, encodeId=e667185502e32, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Oct 01 10:17:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308401, encodeId=786b130840135, content=<a href='/topic/show?id=8323522e503' target=_blank style='color:#2F92EE;'>#急性心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52275, encryptionId=8323522e503, topicName=急性心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326899, encodeId=1f3d132689907, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486457, encodeId=2d29148645e21, content=<a href='/topic/show?id=76291384571' target=_blank style='color:#2F92EE;'>#PCI术后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13845, encryptionId=76291384571, topicName=PCI术后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ea78134582, createdName=12499e01m49暂无昵称, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080246, encodeId=af52108024691, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73be5472067, createdName=MYR哈哈哈哈, createdTime=Wed Dec 15 09:53:51 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1207554, encodeId=7ebc120e554e1, content=很有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4da6463967, createdName=ms6000000942294328, createdTime=Thu Mar 31 15:00:59 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633868, encodeId=1275163386886, content=<a href='/topic/show?id=578d13843ad' target=_blank style='color:#2F92EE;'>#PCI术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13843, encryptionId=578d13843ad, topicName=PCI术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea4322051797, createdName=zxl736, createdTime=Sun Nov 27 09:17:47 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855027, encodeId=e667185502e32, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Oct 01 10:17:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308401, encodeId=786b130840135, content=<a href='/topic/show?id=8323522e503' target=_blank style='color:#2F92EE;'>#急性心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52275, encryptionId=8323522e503, topicName=急性心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326899, encodeId=1f3d132689907, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486457, encodeId=2d29148645e21, content=<a href='/topic/show?id=76291384571' target=_blank style='color:#2F92EE;'>#PCI术后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13845, encryptionId=76291384571, topicName=PCI术后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ea78134582, createdName=12499e01m49暂无昵称, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080246, encodeId=af52108024691, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73be5472067, createdName=MYR哈哈哈哈, createdTime=Wed Dec 15 09:53:51 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1207554, encodeId=7ebc120e554e1, content=很有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4da6463967, createdName=ms6000000942294328, createdTime=Thu Mar 31 15:00:59 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633868, encodeId=1275163386886, content=<a href='/topic/show?id=578d13843ad' target=_blank style='color:#2F92EE;'>#PCI术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13843, encryptionId=578d13843ad, topicName=PCI术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea4322051797, createdName=zxl736, createdTime=Sun Nov 27 09:17:47 CST 2022, time=2022-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855027, encodeId=e667185502e32, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Oct 01 10:17:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308401, encodeId=786b130840135, content=<a href='/topic/show?id=8323522e503' target=_blank style='color:#2F92EE;'>#急性心梗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52275, encryptionId=8323522e503, topicName=急性心梗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326899, encodeId=1f3d132689907, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486457, encodeId=2d29148645e21, content=<a href='/topic/show?id=76291384571' target=_blank style='color:#2F92EE;'>#PCI术后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13845, encryptionId=76291384571, topicName=PCI术后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ea78134582, createdName=12499e01m49暂无昵称, createdTime=Thu Dec 16 05:17:47 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080246, encodeId=af52108024691, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=73be5472067, createdName=MYR哈哈哈哈, createdTime=Wed Dec 15 09:53:51 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2021-12-15 MYR哈哈哈哈

    学习

    0

相关资讯

唐礼江:STEMI患者罪犯血管血流正常时的血运重建策略

一、PPCI术后常见并发症 急诊直接冠状动脉介入治疗(PPCI)具有再通率高、残余狭窄率低等优点,是目前公认STEMI患者首选治疗方法。然而,随着PPCI的日益推广应用,有些患者在接受急诊直接支架植入术后却出现梗死相关血管无复流或慢血流、随访期内支架贴壁不良、支架内血栓形成、再灌注心肌损伤等并发症,从而影响心肌灌注和心功能恢复,对心肌梗死患者近期及远期预后造成不良影响。 临床研究发

JAHA:≥75岁STEMI患者急诊介入治疗后替格瑞洛优于氯吡格雷

自2011年以来,接受急诊经皮冠状动脉介入治疗(PCI)的ST段抬高心肌梗死(STEMI)的大多数≥75岁的老年患者接受了更有效的P2Y12抑制剂替格瑞洛治疗。

病例:从STEMI合并高血压

男性,59岁,公务员 主诉:胸闷10余天 现病史: 1.10余天前,无诱因出现持续胸闷不适,范围巴掌大小,伴双侧肩部胀痛, 头昏,大 汗。自行未做处理。 2. 当地医院就诊考虑“急性广泛前壁心肌梗死”,给予尿激酶溶栓,约1小时患者闷痛症状缓解,心电图:加速性室性逸搏心律。院外给予冠心病II级预防处理。 3. 1天前,再次出现胸闷不适,范围不变,持续约20分钟,休息后缓解。 4. 高

NEJM:STEMI类似病症-病例报道

住院期间CT引导穿刺活检显示低分化的非小细胞癌。住院期间的心电图显示ST段抬高的情况类似,但在第二次入院时它们变得更加突出。该情况被认为是由于心肌的肿瘤侵袭所致,未进行冠状动脉血管造影。

Lancet:远端缺血调节不能降低STEMI患者心源性临床事件风险

研究认为,STEMI患者接受PPCI治疗12个月时,远端缺血预处理不能改善临床心源性死亡或心力衰竭住院风险

NEJM:STEMI多支血管完全血运重建获益(COMPLETE研究)

作者:北京安贞医院周玉杰团队 娄亚柯 高雅楠 刘巍 急诊PCI广泛应用于ST段抬高型心肌梗死(STEMI)患者的再灌注治疗中。STEMI患者往往存在多支血管病变,研究已经证实对STEMI患者的罪犯病变行PCI治疗可以降低心血管死亡率和心肌梗死再发风险。然而,对于非罪犯病变是否需要处理目前尚无定论,非罪犯病变PCI治疗能否进一步降低远期不良事件发生风险目前也仍未可知。COMPL

拓展阅读

急诊PCI术中右冠脉支架后破裂,球囊封堵成功

急性下壁心肌梗死患者急诊冠状动脉造影显示粗大右冠脉上斜形开口,中段弥漫长病变严重狭窄,远端3段末完全闭塞。

TCT 2020丨COMPARE CRUSH试验:PCI术前使用普拉格雷粉碎片剂无再灌注益处

既往研究包括CRUSH和MOJITO研究,已经为普拉格雷或替格瑞洛粉碎片剂能够加速P2Y??抑制剂的药效学作用提供了支持,从而产生更强的抗血小板作用。TCT 2020上公布的COMPARE CRUSH

PCI术中发现冠状动脉慢血流 怎样处理避免复发胸痛?

本例患者因持续性胸骨后疼痛入院,诊断为急性下壁心肌梗死。行PCI术时,发现右冠状动脉慢血流。冠状动脉慢血流的患者超过80%有再发性胸痛,严重影响患者的生活质量。下面要我们看一下此病例的诊断要点和注意事项。【一般情况】男,48岁,汉族。【主诉】持续性胸骨后疼痛2小时。【病史摘要】患者今日6:30开始无明显诱因下出现持续性胸痛,疼痛位于胸骨中段,手掌大小,疼痛性质不详,向两侧肩背及双上臂放射,休息后不

JACC:PCI术后存在时间依赖的内皮或非内皮依赖的舒缩功能紊乱

    由于动脉粥样硬化导致的血管壁完整性的破坏通常伴有血管调节功能的损害、局部血栓形成和炎症,以及血管壁的重塑如动脉瘤或适应性/狭窄性重塑。尽管可以通过经皮冠状动脉介入术解除血管阻塞,但内皮功能紊乱和动脉中层/外膜受到机械压力的作用,会在血管内形成血栓最终导致临床预后不良。药物涂层支架植入后的内皮再生延迟与晚期支架内血栓形成相关,但矛盾的是,药物涂层支架植入术后内皮